Lin Yuansheng, An Jianzhong, Zhuo Xingli, Qiu Yingzhuo, Xie Wenjing, Yao Wei, Yin Dan, Wu Linpeng, Lei Dian, Li Chenghui, Xie Yuanguang, Hu Ahu, Li Shengjun
Department of Emergency and Critical Care Medicine, Suzhou Science & Technology Town Hospital, Gusu School, Nanjing Medical University, Suzhou, People's Republic of China.
Int J Gen Med. 2022 May 3;15:4635-4647. doi: 10.2147/IJGM.S359987. eCollection 2022.
Spindle and kinetochore-associated complex subunit 3 (SKA3) plays important roles in promoting the migration and the invasion of various human cancer cells. There are a few studies on SKA3 in lung adenocarcinoma (LUAD), but the in-depth analysis of the expression of SKA3 and the correlated possible immune mechanism of SKA3 in LUAD are not clear.
In our study, the expression and survival data of SKA3 were analyzed in LUAD using TIMER, Oncomine, UALCAN, cBioPortal, LinkedOmics, Human Protein Atlas, and Kaplan-Meier plotter. Then, quantitative PCR was used to verify the expression differences of SKA3 between LUAD tissues of mice and the normal tissues.
We established that the expression of SKA3 in the LUAD group was remarkably higher than that in the normal group. Additionally, high SKA3 expression was linked to poorer survival in LUAD. Moreover, SKA3 expression had a remarkable negative correlation with the immune infiltration of B cells, macrophages, and CD4+ T cells. SKA3 was markedly negatively related to the immune type biomarkers of T cells and B cells in LUAD. The elevated expression of SKA3 with LUAD in enriched B cells, CD4+ T cells, CD8+ T cells, macrophages and Treg cells had worse prognosis, respectively. Functional network analysis showed that SKA3 regulated the mitotic cell cycle, mitosis, chromosome segregation and cell division via pathways.
In summary, our study suggested that SKA3 was highly expressed in LUAD and SKA3 might function as a prognostic biomarker in LUAD. Besides, SKA3 may be a candidate oncogene, which correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
纺锤体和动粒相关复合体亚基3(SKA3)在促进多种人类癌细胞的迁移和侵袭中发挥重要作用。关于SKA3在肺腺癌(LUAD)中的研究较少,但其在LUAD中的表达深入分析以及相关可能的免疫机制尚不清楚。
在我们的研究中,使用TIMER、Oncomine、UALCAN、cBioPortal、LinkedOmics、人类蛋白质图谱和Kaplan-Meier绘图仪分析LUAD中SKA3的表达和生存数据。然后,采用定量PCR验证小鼠LUAD组织与正常组织中SKA3的表达差异。
我们发现LUAD组中SKA3的表达明显高于正常组。此外,高SKA3表达与LUAD患者较差的生存率相关。此外,SKA3表达与B细胞、巨噬细胞和CD4+T细胞的免疫浸润呈显著负相关。SKA3与LUAD中T细胞和B细胞的免疫类型生物标志物明显负相关。SKA3在LUAD中表达升高,在富集的B细胞、CD4+T细胞、CD8+T细胞、巨噬细胞和调节性T细胞中分别具有更差的预后。功能网络分析表明,SKA3通过多种途径调节有丝分裂细胞周期、有丝分裂、染色体分离和细胞分裂。
总之,我们的研究表明SKA3在LUAD中高表达,并且SKA3可能作为LUAD的预后生物标志物。此外,SKA3可能是一种候选癌基因,与肺腺癌的不良预后和免疫浸润相关。